Biomarin Pharmaceutical Inc (BMRN)

Gross profit margin

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Gross profit (ttm)	US$ in thousands	1,929,538	1,858,176	1,754,938	1,686,510	1,629,885	1,575,812	1,523,342	1,440,300	1,404,301	1,356,936	1,352,560	1,329,619	1,282,275	1,298,545	1,328,331	1,411,148	1,391,139	1,334,839	1,258,970	1,198,441
Revenue (ttm)	US$ in thousands	2,443,023	2,373,030	2,261,604	2,184,719	2,123,138	2,059,481	1,999,471	1,903,678	1,871,615	1,827,451	1,829,463	1,891,778	1,815,339	1,822,817	1,822,364	1,813,337	1,772,797	1,694,305	1,597,556	1,518,971
Gross profit margin		78.98%	78.30%	77.60%	77.20%	76.77%	76.52%	76.19%	75.66%	75.03%	74.25%	73.93%	70.28%	70.64%	71.24%	72.89%	77.82%	78.47%	78.78%	78.81%	78.90%

March 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $1,929,538K ÷ $2,443,023K
= 78.98%

The gross profit margin of Biomarin Pharmaceutical Inc has shown a generally positive trend over the past few quarters, reflecting the company's ability to effectively manage its cost of goods sold and generate profits from its core operations. The margin has been consistently above 70%, indicating strong pricing power and operational efficiency in producing and selling its products.

The gross profit margin has been steadily increasing, reaching a high of 78.98% as of March 31, 2024, which suggests that the company has been able to maintain a healthy level of profitability relative to its revenue during this period. This improvement in gross profit margin over time is a positive indicator of the company's ability to control its production costs and optimize its revenue streams.

Overall, the upward trend in Biomarin Pharmaceutical Inc's gross profit margin signifies financial strength and effective cost management, which are essential elements for sustaining profitability and driving overall business performance.